Details of the Drug Formulations

General Information of Drug (ID: DMEH3O7)

• Drug Name: Rifamycin Drug Info
• Synonyms: Rifamycin SV; Rifamycin SV MMX; Rifamycin sodium; CB-01-11; Rifamycin (oral controlled-release, gastrointestinal-specific); Rifamycin (oral controlled-release, gastrointestinal-specific), Cosmo/Dr Falk/Santarus

Indication

Disease Entry	ICD 11	Status	REF
Diarrhea	ME05.1	Approved	[1]
Infectious disease	1A00-CA43.1	Phase 3	[2]

• Cross-matching ID:
  PubChem CID: 6324616
  ChEBI ID: CHEBI:29673
  CAS Number: 6998-60-3
  TTD ID: D0FX2Q
  VARIDT ID: DR00614
  ACDINA ID: D01389

Full List of Drug Formulations Containing This Drug

Rifamycin 194mg tablet

Company	Formulation ID	FDA Description
Redhill	F23273	Ammonio Methacrylate Copolymer (Type B); Ascorbic Acid; Glyceryl Distearate; Lecithin; Magnesium Stearate; Mannitol; Methacrylic Acid And Methyl Methacrylate Copolymer (1:2); Polyethylene Glycol 6000; Colloidal Silicon Dioxide; Talc; Titanium Dioxide; Triethylcitrate; Yellow Ferric Oxide

References

• [1] Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4832-E4840.
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4570).